Evaxion announces Executive Management Changes To Strengthen The AI-strategy; Christian Kanstrup Hired as New CEO
Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion" or the "Company"), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today announced:
Evaxion